Supplier
Lafayette Pain Care, P.C.
Lafayette Pain Care, P.C. was paid $6.05M by Medicaid between Jan 2018 and Dec 2024, across 60 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 28% of everything it billed.
33Billing provider infoLAFAYETTE PAIN CARE, P.C.
LAFAYETTE, IN 47905
LAFAYETTE, IN 47905
33aNPI1205189594assigned 10/24/2012
33bProvider typeDurable Medical Equipment & Medical Supplies
28Total paid$6.05M
24GClaims224,690
24DCodes billed60
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Durable Medical Equipment & Medical Supplies providers in Indiana
Rank by total paid#17 of 560
Median peer was paid$29.96
This provider vs. median201,912×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 56,493 | $409K | |
| 2019 | 47,331 | $717K | |
| 2020 | 30,221 | $519K | |
| 2021 | 28,095 | $888K | |
| 2022 | 19,563 | $1.08M | |
| 2023 | 24,122 | $1.34M | |
| 2024incomplete | 18,865 | $1.09M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 28% | 35,285 | 29,683 | $1.67M |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 23% | 44,949 | 40,762 | $1.41M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 15% | 31,244 | 24,292 | $878K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 8.1% | 11,237 | 10,568 | $491K |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed | 7.4% | 5,707 | 5,427 | $448K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 4.7% | 3,907 | 3,352 | $285K |
| 64635 | 3.0% | 1,612 | 1,087 | $179K | |
| 64493 | 2.7% | 2,712 | 1,735 | $166K | |
| 62323 | 1.8% | 1,988 | 1,406 | $112K | |
| 64494 | 1.4% | 2,661 | 1,712 | $87K | |
| 64636 | 1.3% | 1,638 | 1,082 | $77K | |
| 95886 | <1% | 646 | 563 | $57K |
48 more codes
| 80361 | <1% | 5,382 | $55K | |
| 95913 | <1% | 318 | $44K | |
| 64495 | <1% | 1,114 | $19K | |
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed | <1% | 4,894 | $19K |
| 95912 | <1% | 111 | $17K | |
| 80365 | <1% | 1,609 | $14K | |
| 64490 | <1% | 86 | $5K | |
| J1030 | Injection, methylprednisolone acetate, 40 mg | <1% | 1,920 | $3K |
| 64491 | <1% | 87 | $3K | |
| 64633 | <1% | 52 | $3K | |
| 99406 | <1% | 230 | $2K | |
| 27096 | <1% | 36 | $1K | |
| 80355 | <1% | 138 | $1K | |
| 80373 | <1% | 474 | $1K | |
| 64634 | <1% | 53 | $1K | |
| 62321 | <1% | 19 | $1K | |
| 62370 | <1% | 21 | $705.49 | |
| 99442 | <1% | 85 | $523.60 | |
| 20553 | <1% | 12 | $286.03 | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 32 | $279.48 |
| Q9966 | Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | <1% | 1,252 | $60.79 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 42 | $45.94 |
| 80354 | <1% | 83 | $15.00 | |
| G9578 | Documentation of signed opioid treatment agreement at least once during opioid therapy | 0% | 10,366 | $0.00 |
| G9562 | Patients who had a follow-up evaluation conducted at least every three months during opioid therapy | 0% | 10,333 | $0.00 |
| G8427 | Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | 0% | 10,810 | $0.00 |
| G8730 | Pain assessment documented as positive using a standardized tool and a follow-up plan is documented | 0% | 7,502 | $0.00 |
| 1124F | 0% | 6,269 | $0.00 | |
| 4004F | 0% | 2,869 | $0.00 | |
| G9584 | Patient evaluated for risk of misuse of opiates by using a brief validated instrument (e.g., opioid risk tool, soapp-r) or patient interviewed at least once during opioid therapy | 0% | 10,270 | $0.00 |
| 80348 | 0% | 81 | $0.00 | |
| 80360 | 0% | 81 | $0.00 | |
| 80372 | 0% | 83 | $0.00 | |
| 83992 | 0% | 81 | $0.00 | |
| G9500 | Radiation exposure indices documented in final report for procedure using fluoroscopy | 0% | 205 | $0.00 |
| 80362 | 0% | 81 | $0.00 | |
| 80356 | 0% | 81 | $0.00 | |
| 80369 | 0% | 81 | $0.00 | |
| 1036F | 0% | 3,237 | $0.00 | |
| 80371 | 0% | 81 | $0.00 | |
| 80363 | 0% | 80 | $0.00 | |
| 1123F | 0% | 49 | $0.00 | |
| 80358 | 0% | 81 | $0.00 | |
| 80352 | 0% | 77 | $0.00 | |
| 80359 | 0% | 81 | $0.00 | |
| 80335 | 0% | 81 | $0.00 | |
| 80357 | 0% | 80 | $0.00 | |
| G9585 | Patient not evaluated for risk of misuse of opiates by using a brief validated instrument (e.g., opioid risk tool, soapp-r) or patient not interviewed at least once during opioid therapy | 0% | 14 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialSIDDIQUI, SHAZIA (OWNER)
| Provider | Location | Paid |
|---|---|---|
| LPC Surgery Center LLC | Lafayette, IN | $404K |
| Kokomo Ambulatory Surgery Center | Kokomo, IN | $163K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.